AMP126

General Information


DRACP ID  DRACP03558

Peptide Name   AMP126

Sequence  KWCRKWQWRGVKFIKCV

Sequence Length  17

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP03558

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C107H163N31O19S2

Absent amino acids  ADEHLMNPSTY

Common amino acids  K

Mass  253736

Pl  11.22

Basic residues  6

Acidic residues  0

Hydrophobic residues  7

Net charge  6

Boman Index  -3111

Hydrophobicity  -61.76

Aliphatic Index  57.06

Half Life 
  Mammalian: 1.3 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  16625

Absorbance 280nm  1039.06

Polar residues  3

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 23893489

Title  In vitro activity of novel in silico-developed antimicrobial peptides against a panel of bacterial pathogens

Doi Not available

Year  2013

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  7558

DRACP is developed by Dr.Zheng's team.